Coya Therapeutics (COYA) Interest Coverage Ratio (2022 - 2026)
Coya Therapeutics (COYA) reported Interest Coverage Ratio of 12.64 for Q1 2026, down 587.4% on a YoY basis from 2.59 in Q1 2025, and down 431.7% sequentially from 2.38 in Q4 2025.
Coya Therapeutics (COYA) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Coya Therapeutics (COYA) has 5 years of Interest Coverage Ratio data on file, last reported at 12.64 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 587.4% year-over-year to 12.64; the trailing twelve-month figure through Mar 2026 stood at 37.25 (down 699.93% YoY), and the FY2025 full-year result was 1.69, up 20.16% from the prior year.
- Interest Coverage Ratio slipped to 12.64 in Q1 2026, from 2.38 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.32 in Q4 2023 to a low of 12.64 in Q1 2026.
- A 5-year average of 2.45 and a median of 1.92 in 2025 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio surged 116.11% in 2023 and slumped 587.4% in 2026, its largest moves.
- Tracing COYA's Interest Coverage Ratio over 5 years: stood at 2.0 in 2022, then surged by 116.11% to 0.32 in 2023, then slumped by 255.55% to 0.5 in 2024, then tumbled by 373.59% to 2.38 in 2025, then sank by 431.7% to 12.64 in 2026.
- Business Quant data shows COYA's Interest Coverage Ratio at 12.64 in Q1 2026, 2.38 in Q4 2025, and 1.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Coya Therapeutics | 97.14 Mn | 46.42 Mn | - | -12.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.64 |
| Dec 31, 2025 | -2.38 |
| Sep 30, 2025 | -1.00 |
| Jun 30, 2025 | -2.50 |
| Mar 31, 2025 | -1.84 |
| Dec 31, 2024 | -0.50 |
| Sep 30, 2024 | -1.14 |
| Jun 30, 2024 | -0.99 |
| Mar 31, 2024 | -0.56 |
| Dec 31, 2023 | 0.32 |
| Sep 30, 2023 | -3.69 |
| Jun 30, 2023 | -2.75 |
| Mar 31, 2023 | -2.68 |
| Dec 31, 2022 | -2.00 |